Coronavirus

 
Social, Racial Disparities in Flu, COVID-19, RSV Vaccine Uptake: Daily Dose
October 31, 2024

Your daily dose of the clinical news you may have missed.

ACIP Recommends 2nd COVID-19 Shot for Older Adults, Immunocompromised Individuals
October 24, 2024

CDC Director Mandy Cohen endorsed the ACIP's recommendations, which also call for flexible dosing under shared clinical decision making.

Pfizer-BioNTech COVID-19 Vaccine May Reduce Risk of Long COVID in Older Adults
October 21, 2024

IDWeek 2024: Older adults vaccinated with BNT162b2 (Comirnaty) had approximately half the odds of developing long COVID vs unvaccinated adults, according to new data.

IDWeek 2024: Novavax Reports Positive Data for Novel Influenza and Flu-COVID-19 Combination Vaccines
October 18, 2024

IDWeek2024: The nanoparticle influenza vaccine and combination flu-Covid-19 shot produced immunogenicity comparable to or higher than comparator vaccines.

New Data Highlight Social, Racial Disparities in Flu, COVID-19, RSV Vaccine Uptake
October 17, 2024

IDWeek 2024: Black individuals were less likely to be vaccinated against all 3 respiratory viruses than White individuals, according to new research.

Remdesivir Plus Dexamethasone Reduces Mortality Risk among Adults Hospitalized with COVID-19
October 10, 2024

Remdesivir plus dexamethasone was associated with reduced 14- and 28-day mortality vs dexamethasone alone, according to a large study of adults hospitalized with COVID-19.

COVID-19 Linked to Long-Term Risk of MACE, Especially Among Adults with non-O Blood Types
October 09, 2024

Prior SARS-CoV-2 infection was associated with a 2-fold increased risk for MACE for up to 3 years, even among people with no history of CVD, in a new analysis of UK Biobank data.

7 Drugs Approved for Primary Care: Q3 2024
September 26, 2024

Updated mRNA COVID-19 vaccines, the first orally disintegrating tablet approved for pregnancy prevention, and 5 more.

CDC COVID-19 Vaccine Bridge Access Program Ends 4 Months Earlier than Planned
September 09, 2024

The Bridge Access Program allowed Americans who are uninsured or underinsured to receive COVID-19 vaccination at not cost and was ended abruptly last month.

Moderna launches COVID booster campaign
September 05, 2024

The “Do It For You & Them” campaign focuses on the impact that virus has on day-to-day lives.